The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking ...
The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...
Gilead's once-yearly injectable lenacapavir shows promising results in HIV prevention, with a 96% reduction in infections and plans for regulatory filings by 2027.
Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Russia continues to pound Ukraine with missile strikes, often targeting infrastructure like power plants. That has caused ...
A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...
FOX 5 Atlanta on MSN5d
Injectable HIV preventative lenacapavir touted as breakthrough by Emory expertsA new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback